Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

1.40
Delayed Data
As of Sep 22
 +0.05 / +3.70%
Today’s Change
1.20
Today|||52-Week Range
27.36
-73.04%
Year-to-Date
No recent news for Anthera Pharmaceuticals Inc.

Today’s Trading

Previous close1.35
Today’s open1.36
Day’s range1.34 - 1.47
Volume410,618
Average volume (3 months)284,579
Market cap$15.3M
Dividend yield--
Data as of 4:00pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)-62.63%
Earnings growth (this year)--
Earnings growth (next 5 years)+78.00%
Revenue growth (last year)-95.45%
P/E ratioNM
Price/Sales184.93
Price/Book2.09

Competitors

 Today’s
change
Today’s
% change
IMRNImmuron Ltd-0.16-2.62%
DMPIDelMar Pharmaceutica...-0.10-10.18%
EYEGEyeGate Pharmaceutic...+0.06+5.41%
KTOVKitov Pharmaceutical...-0.03-1.55%
Data as of 4:00pm ET, 09/22/2017

Financials

Next reporting dateNovember 3, 2017
EPS forecast (this quarter)-$0.91
Annual revenue (last year)$145.0K
Annual profit (last year)-$55.5M
Net profit margin-38,291.72%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Craig Thompson
CAO, Senior VP-Finance &
Administration
May Liu
Corporate headquarters
Hayward, California

Forecasts